$ACCD
Accolade, Inc. Stock $accd

$accd Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000148164624000020 Filed on April 26, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$110.5M	$124.8M	$414.3M
YoY Change	18.49%	26.06%	14.09%
Cost Of Revenue	$58.61M	$58.20M	$221.5M
YoY Change	8.13%	14.0%	11.38%
Gross Profit	$51.86M	$66.64M	$192.7M
YoY Change	32.88%	38.89%	17.36%
Gross Profit Margin	46.94%	53.38%	46.52%
Selling, General & Admin	$44.20M	$63.45M	$162.2M
YoY Change	-34.04%	-6.05%	-10.06%
% of Gross Profit	85.24%	95.22%	84.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.39M	$11.31M	$45.16M
YoY Change	-10.72%	-2.77%	-2.62%
% of Gross Profit	20.04%	16.97%	23.43%
Operating Expenses	$80.90M	$74.75M	$306.5M
YoY Change	2.86%	-5.57%	-51.17%
Operating Profit	-$29.05M	-$8.118M	-$114.5M
YoY Change	-26.7%	-73.97%	-75.31%
Interest Expense	$1.697M	$1.612M	$5.952M
YoY Change	84.26%	118.13%	2234.12%
% of Operating Profit
Other Income/Expense, Net	$94.00K	-$493.0K	$9.931M
YoY Change	-75.9%	1269.44%	-66306.67%
Pretax Income	-$27.26M	-$6.778M	-$98.57M
YoY Change	-28.87%	-77.77%	-78.72%
Income Tax	$335.0K	$729.0K	$1.235M
% Of Pretax Income
Net Earnings	-$27.59M	-$7.507M	-$99.81M
YoY Change	-28.16%	-75.33%	-78.29%
Net Earnings / Revenue	-24.98%	-6.01%	-24.09%
Basic Earnings Per Share	-$0.35		-$1.33
Diluted Earnings Per Share	-$0.35	-$0.10	-$1.33
COMMON SHARES
Basic Shares Outstanding	78.36M shares		74.91M shares
Diluted Shares Outstanding	78.12M shares		74.91M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$230.6M	$237.0M
YoY Change	-23.85%	-26.18%
Cash & Equivalents	$188.7M	$185.7M
Short-Term Investments	$41.93M	$51.32M
Other Short-Term Assets	$16.91M	$20.18M
YoY Change	-12.42%	11.04%
Inventory
Prepaid Expenses
Receivables	$20.28M	$21.80M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$275.3M	$284.9M
YoY Change	-21.01%	-22.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$19.65M	$19.14M
YoY Change	-56.02%	29.65%
Goodwill	$278.2M	$278.2M
YoY Change	0.0%	0.0%
Intangibles	$156.5M	$165.4M
YoY Change	-18.83%	-18.6%
Long-Term Investments
YoY Change
Other Assets	$2.095M	$2.553M
YoY Change	-81.82%	57.2%
Total Long-Term Assets	$492.1M	$503.2M
YoY Change	-6.66%	-6.31%
TOTAL ASSETS
Total Short-Term Assets	$275.3M	$284.9M
Total Long-Term Assets	$492.1M	$503.2M
Total Assets	$767.4M	$788.2M
YoY Change	-12.37%	-12.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.139M	$13.75M
YoY Change	49.04%	35.39%
Accrued Expenses	$40.29M	$10.74M
YoY Change	-16.62%	-8.58%
Deferred Revenue	$38.75M	$34.77M
YoY Change	-12.32%	-1.2%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$98.44M	$107.9M
YoY Change	-12.68%	-9.68%
LONG-TERM LIABILITIES
Long-Term Debt	$208.8M	$208.5M
YoY Change	-26.16%	-26.15%
Other Long-Term Liabilities	$157.0K	$156.0K
YoY Change	-99.4%	-23.15%
Total Long-Term Liabilities	$157.0K	$156.0K
YoY Change	-99.95%	-23.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$98.44M	$107.9M
Total Long-Term Liabilities	$157.0K	$156.0K
Total Liabilities	$332.1M	$342.7M
YoY Change	-21.21%	-20.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.082B	-$1.054B
YoY Change	8.96%	10.46%
Common Stock	$8.000K	$8.000K
YoY Change	0.0%	14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$435.3M	$445.5M
YoY Change
Total Liabilities & Shareholders Equity	$767.4M	$788.2M
YoY Change	-12.37%	-12.73%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$27.59M	-$7.507M	-$99.81M
YoY Change	-28.16%	-75.33%	-78.29%
Depreciation, Depletion And Amortization	$10.39M	$11.31M	$45.16M
YoY Change	-10.72%	-2.77%	-2.62%
Cash From Operating Activities	-$7.120M	$5.951M	-$16.17M
YoY Change	-63.08%	-332.55%	-60.28%
INVESTING ACTIVITIES
Capital Expenditures	$713.0K	$2.107M	$4.935M
YoY Change	-78.89%	-12.68%	134.44%
Acquisitions			$0.00
YoY Change
Other Investing Activities	$10.00M	-$51.15M	-$51.15M
YoY Change
Cash From Investing Activities	$8.045M	-$53.25M	-$63.63M
YoY Change	-338.23%	2106.96%	780.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.066M	3.004M	-$55.57M
YoY Change	-53.58%	618.66%	-1856.78%
NET CHANGE
Cash From Operating Activities	-$7.120M	5.951M	-$16.17M
Cash From Investing Activities	$8.045M	-53.25M	-$63.63M
Cash From Financing Activities	$2.066M	3.004M	-$55.57M
Net Change In Cash	$2.991M	-44.30M	-$135.4M
YoY Change	-116.42%	872.75%	202.36%
FREE CASH FLOW
Cash From Operating Activities	-$7.120M	$5.951M	-$16.17M
Capital Expenditures	$713.0K	$2.107M	$4.935M
Free Cash Flow	-$7.833M	$3.844M	-$21.10M
YoY Change	-65.44%	-177.31%	-50.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-123124000	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	299705000	usd
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001481646
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-02-29
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-29
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-39348
CY2024	dei	Entity Registrant Name EntityRegistrantName	ACCOLADE, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	01-0969591
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	1201 Third Avenue
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1700
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98101
CY2024	dei	City Area Code CityAreaCode	206
CY2024	dei	Local Phone Number LocalPhoneNumber	926-8100
CY2024	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2024	dei	Trading Symbol TradingSymbol	ACCD
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	false
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	926100000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	78356908	shares
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	dei	Auditor Name AuditorName	KPMG LLP
CY2024	dei	Auditor Location AuditorLocation	Philadelphia, PA
CY2024	dei	Auditor Firm AuditorFirmId	185
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	185718000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	321083000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	51315000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	0	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21800000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23435000	usd
CY2024Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	5902000	usd
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	3260000	usd
CY2024Q1	accd	Deferred Acquisition Costs Current DeferredAcquisitionCostsCurrent	4369000	usd
CY2023Q1	accd	Deferred Acquisition Costs Current DeferredAcquisitionCostsCurrent	4022000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15808000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14149000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	284912000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	365949000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19140000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14763000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28340000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29525000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	278191000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	278191000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	165407000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	203202000	usd
CY2024Q1	accd	Deferred Acquisition Costs Non Current DeferredAcquisitionCostsNonCurrent	9608000	usd
CY2023Q1	accd	Deferred Acquisition Costs Non Current DeferredAcquisitionCostsNonCurrent	9815000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2553000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1624000	usd
CY2024Q1	us-gaap	Assets Assets	788151000	usd
CY2023Q1	us-gaap	Assets Assets	903069000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	13749000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10155000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	10736000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	11744000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23392000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39346000	usd
CY2024Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	18552000	usd
CY2023Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	15694000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	34770000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35191000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6651000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7284000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	107850000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	119414000	usd
CY2024Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	208482000	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	282323000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26077000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27189000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	156000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	203000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	121000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	154000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	342686000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	429283000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78070781	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78070781	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73089075	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73089075	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1499603000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1428073000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-47000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1054099000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-954294000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	445465000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	473786000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	788151000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	903069000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	414292000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	363142000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	310021000	usd
CY2024	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	222232000	usd
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	198905000	usd
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	169019000	usd
CY2024	accd	Product And Technology Expense ProductAndTechnologyExpense	99159000	usd
CY2023	accd	Product And Technology Expense ProductAndTechnologyExpense	101347000	usd
CY2022	accd	Product And Technology Expense ProductAndTechnologyExpense	83664000	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	100066000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	99113000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	86765000	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	62124000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	81209000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	99106000	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	45164000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46377000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	42608000	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	299705000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-45416000	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	306513000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	627751000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	266727000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-114453000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-463514000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-125725000	usd
CY2024	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	5952000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	255000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2905000	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9931000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-133000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-98570000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-463274000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-128763000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1235000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3624000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5639000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-99805000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-459650000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-123124000	usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.45
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.45
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.93
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.93
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74906938	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74906938	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71279831	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71279831	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63823270	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63823270	shares
CY2024	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-47000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-99852000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-459650000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-123124000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	390848000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	456593000	usd
CY2022	accd	Issuance Of Replacement Awards In Connection With Acquisition IssuanceOfReplacementAwardsInConnectionWithAcquisition	6729000	usd
CY2022	accd	Contingent Share Earnout In Connection With Acquisitions ContingentShareEarnoutInConnectionWithAcquisitions	73481000	usd
CY2022	accd	Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits	8522000	usd
CY2022	accd	Adjustments To Additional Paid In Capital Capped Calls Purchased AdjustmentsToAdditionalPaidInCapitalCappedCallsPurchased	34503000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4309000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	72939000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-123124000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	855794000	usd
CY2023	accd	Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits	2071000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2927000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	72644000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-459650000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	473786000	usd
CY2024	accd	Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits	7011000	usd
CY2024	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3579000	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	60941000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-47000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-99805000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	445465000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-99805000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-459650000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45164000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46377000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42608000	usd
CY2024	accd	Amortization Of Deferred Contract Acquisition Costs AmortizationOfDeferredContractAcquisitionCosts	5437000	usd
CY2023	accd	Amortization Of Deferred Contract Acquisition Costs AmortizationOfDeferredContractAcquisitionCosts	3698000	usd
CY2022	accd	Amortization Of Deferred Contract Acquisition Costs AmortizationOfDeferredContractAcquisitionCosts	2945000	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-45416000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3997000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6132000	usd
CY2024	us-gaap	Paid In Kind Interest PaidInKindInterest	1540000	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	1660000	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	1673000	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-215000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	60941000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	72644000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	72939000	usd
CY2024	accd	Gain Loss On Repurchase Of Convertible Notes GainLossOnRepurchaseOfConvertibleNotes	9268000	usd
CY2023	accd	Gain Loss On Repurchase Of Convertible Notes GainLossOnRepurchaseOfConvertibleNotes	0	usd
CY2022	accd	Gain Loss On Repurchase Of Convertible Notes GainLossOnRepurchaseOfConvertibleNotes	0	usd
CY2024	accd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	1007000	usd
CY2023	accd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	-4106000	usd
CY2022	accd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	11829000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3380000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1131000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1899000	usd
CY2024	accd	Increase Decrease In Deferred Contract Acquisition Costs IncreaseDecreaseInDeferredContractAcquisitionCosts	5575000	usd
CY2023	accd	Increase Decrease In Deferred Contract Acquisition Costs IncreaseDecreaseInDeferredContractAcquisitionCosts	7314000	usd
CY2022	accd	Increase Decrease In Deferred Contract Acquisition Costs IncreaseDecreaseInDeferredContractAcquisitionCosts	4148000	usd
CY2024	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2404000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3634000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	13986000	usd
CY2024	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-15953000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	157000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2519000	usd
CY2024	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-607000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1627000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2605000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-62350000	usd
CY2024	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	7547000	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	5123000	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1096000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4935000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2105000	usd
CY2024	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	51147000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	99998000	usd
CY2024	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	99998000	usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	259996000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63629000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7228000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-263613000	usd
CY2024	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	65808000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2024	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	355000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2024	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	3579000	usd
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	2927000	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	4703000	usd
CY2024	accd	Proceeds From Stock Option And Warrant Exercises ProceedsFromStockOptionAndWarrantExercises	7017000	usd
CY2023	accd	Proceeds From Stock Option And Warrant Exercises ProceedsFromStockOptionAndWarrantExercises	2064000	usd
CY2022	accd	Proceeds From Stock Option And Warrant Exercises ProceedsFromStockOptionAndWarrantExercises	8600000	usd
CY2024	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1828000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2024	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	60000	usd
CY2024	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8368000	usd
CY2024	accd	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	0	usd
CY2023	accd	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	0	usd
CY2022	accd	Payment For Purchase Of Capped Calls PaymentForPurchaseOfCappedCalls	34443000	usd
CY2024	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	287500000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-55567000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3163000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	257932000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-135365000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-44770000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-68031000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321083000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	365853000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	433884000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	185718000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	321083000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	365853000	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	1640000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1640000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	930000	usd
CY2024	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	28000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	771000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	161000	usd
CY2024	accd	Other Receivable Related To Stock Option Exercises OtherReceivableRelatedToStockOptionExercises	6000	usd
CY2023	accd	Other Receivable Related To Stock Option Exercises OtherReceivableRelatedToStockOptionExercises	13000	usd
CY2022	accd	Other Receivable Related To Stock Option Exercises OtherReceivableRelatedToStockOptionExercises	4000	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	402000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	157000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	122000	usd
CY2024	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	455586000	usd
CY2024	accd	Replacement Awards Issued In Connection With Acquisition ReplacementAwardsIssuedInConnectionWithAcquisition	0	usd
CY2023	accd	Replacement Awards Issued In Connection With Acquisition ReplacementAwardsIssuedInConnectionWithAcquisition	0	usd
CY2022	accd	Replacement Awards Issued In Connection With Acquisition ReplacementAwardsIssuedInConnectionWithAcquisition	6729000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">(b) Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including the fair value of assets acquired and liabilities assumed for business combinations, unbilled revenues and deferred revenues, certain accrued expenses, stock-based compensation, assessment of the useful life and recoverability of long-lived assets, income taxes, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, assessment of the recoverability of goodwill, and the reported amounts of revenues and expenses during the reporting period. To the extent there are material differences between these estimates, judgments, or assumptions and actual results, the Company’s financial statements will be affected.</span></div>
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">(m) Concentration of Credit Risk</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and marketable securities. The Company maintains its cash primarily with domestic financial institutions of high credit quality, which may exceed federal deposit insurance corporation limits. The Company invests its cash equivalents in highly rated money market funds and U.S. treasury bills with original maturities of three months or less. Marketable securities are comprised of U.S. government debt, commercial paper, and U.S. agency debt with original maturities greater than three months. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.</span></div>
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	414292000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	363142000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	310021000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	155157000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	49937000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	12154000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	652000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	274000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	218174000	usd
CY2024	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	34941000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	30567000	usd
CY2024	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	5142000	usd
CY2023	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	3768000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2024	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3950000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2695000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2080000	usd
CY2024	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
CY2023	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
CY2022	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
CY2022Q1	us-gaap	Goodwill Goodwill	577896000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	299705000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	278191000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	278191000	usd
CY2023Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	299705000	usd
CY2022Q2	accd	Goodwill Impairment Adjustment Per Shares Basic GoodwillImpairmentAdjustmentPerSharesBasic	4.20
CY2022Q2	accd	Goodwill Impairment Adjustment Per Shares Diluted GoodwillImpairmentAdjustmentPerSharesDiluted	4.20
CY2022Q2	accd	Goodwill Impairment Test Discount Rate GoodwillImpairmentTestDiscountRate	0.11
CY2022Q2	accd	Goodwill Impairment Test For Current Revenue GoodwillImpairmentTestForCurrentRevenue	1.1
CY2022Q2	accd	Goodwill Impairment Test For Forward Revenue GoodwillImpairmentTestForForwardRevenue	1.8
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	283576000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	118169000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	165407000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	283576000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	80374000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	203202000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37795000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	41488000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	36590000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	34143000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	32125000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9403000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7370000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7370000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	74996000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	165407000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	78037000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	69606000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	58897000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54843000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19140000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14763000	usd
CY2024	accd	Depreciation Depletion And Amortization Excluding Acquired Technology DepreciationDepletionAndAmortizationExcludingAcquiredTechnology	7369000	usd
CY2023	accd	Depreciation Depletion And Amortization Excluding Acquired Technology DepreciationDepletionAndAmortizationExcludingAcquiredTechnology	4889000	usd
CY2022	accd	Depreciation Depletion And Amortization Excluding Acquired Technology DepreciationDepletionAndAmortizationExcludingAcquiredTechnology	6018000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P7Y
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	7285000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	7575000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	7169000	usd
CY2024	us-gaap	Variable Lease Cost VariableLeaseCost	2253000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	2042000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1691000	usd
CY2024	us-gaap	Short Term Lease Cost ShortTermLeaseCost	465000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2024	us-gaap	Sublease Income SubleaseIncome	52000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2024	us-gaap	Lease Cost LeaseCost	9951000	usd
CY2023	us-gaap	Lease Cost LeaseCost	9617000	usd
CY2022	us-gaap	Lease Cost LeaseCost	8860000	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	9293000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	8569000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	8310000	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5841000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2170000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3564000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.058
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	8580000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8582000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7361000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4567000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3730000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4925000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	37745000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5017000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	32728000	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	438000	usd
CY2023Q1	us-gaap	Loans Payable Current LoansPayableCurrent	596000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2715000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1992000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1732000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	528000	usd
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	544000	usd
CY2023Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	347000	usd
CY2024Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	0	usd
CY2023Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	3700000	usd
CY2024Q1	accd	Accrued Software Hardware And Communication Costs AccruedSoftwareHardwareAndCommunicationCosts	1204000	usd
CY2023Q1	accd	Accrued Software Hardware And Communication Costs AccruedSoftwareHardwareAndCommunicationCosts	464000	usd
CY2024Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	4103000	usd
CY2023Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	4117000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10736000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11744000	usd
CY2024Q1	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	180841000	usd
CY2021Q1	accd	Number Of Initial Purchasers Of Capped Call Transactions NumberOfInitialPurchasersOfCappedCallTransactions	2	purchaser
CY2019Q3	accd	Number Of Banks NumberOfBanks	2	bank
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	60941000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	72644000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	72939000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.22
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	14.25
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.69
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y29D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y29D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y29D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0343
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8723769	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	528038	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	47.74
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	901064	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.37
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	304951	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	14.87
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8045792	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	915081	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.06
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	346518	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.45
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	563836	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	20.05
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8050519	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10792	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.25
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1349080	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.41
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	540578	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	19.36
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6171653	shares
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	18454000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6171653	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.87
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y6M
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	18454000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5713200	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.17
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y2M12D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	17827000	usd
CY2024	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.035
CY2024	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	100000	usd
CY2024	accd	Defined Contribution Plan Employers Matching Contribution Vesting Number Of Years Of Service DefinedContributionPlanEmployersMatchingContributionVestingNumberOfYearsOfService	P4Y
CY2024	accd	Defined Contribution Plan Employer Discretionary Profit Sharing Contribution Vesting Number Of Years Of Service DefinedContributionPlanEmployerDiscretionaryProfitSharingContributionVestingNumberOfYearsOfService	P4Y
CY2024	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2903000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3231000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2278000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-99594000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-463848000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-129569000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1024000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	574000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	806000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-98570000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-463274000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-128763000	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	668000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	156000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	124000	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	380000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	90000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	76000	usd
CY2024	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	200000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	127000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	202000	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1248000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	373000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	402000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1638000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7935000	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2359000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1941000	usd
CY2024	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-13000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-47000	usd
CY2024	accd	Deferred Income Tax Expense Benefit Including Adjustments DeferredIncomeTaxExpenseBenefitIncludingAdjustments	-13000	usd
CY2023	accd	Deferred Income Tax Expense Benefit Including Adjustments DeferredIncomeTaxExpenseBenefitIncludingAdjustments	-3997000	usd
CY2022	accd	Deferred Income Tax Expense Benefit Including Adjustments DeferredIncomeTaxExpenseBenefitIncludingAdjustments	-6041000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1235000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3624000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5639000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2024	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.031
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.028
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.045
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	-0.018
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	-0.021
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.209
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.008
CY2024	accd	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCosts	0
CY2023	accd	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCosts	0
CY2022	accd	Effective Income Tax Rate Reconciliation Nondeductible Expense Transaction Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCosts	-0.011
CY2024	accd	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	0
CY2023	accd	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	0
CY2022	accd	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	0.011
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.086
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.025
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.119
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.219
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.013
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.008
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.044
CY2023	accd	Reversal Of Deferred Tax Liability ReversalOfDeferredTaxLiability	3899000	usd
CY2024Q1	accd	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	126404000	usd
CY2023Q1	accd	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	113740000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	2310000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5599000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10550000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	32741000	usd
CY2024Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	2959000	usd
CY2023Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3092000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	9271000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	6248000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1146000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	869000	usd
CY2024Q1	accd	Deferred Tax Asset Capitalized Research And Development DeferredTaxAssetCapitalizedResearchAndDevelopment	23507000	usd
CY2023Q1	accd	Deferred Tax Asset Capitalized Research And Development DeferredTaxAssetCapitalizedResearchAndDevelopment	10931000	usd
CY2024Q1	accd	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	8170000	usd
CY2023Q1	accd	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	10086000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	178097000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	175610000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6220000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7696000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5989000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	7478000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5989000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7478000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	231000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	218000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	64782000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	175610000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	125810000	usd
CY2024	accd	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Net Operating Losses And Temporary Differences Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToNetOperatingLossesAndTemporaryDifferencesAmount	2487000	usd
CY2023	accd	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Net Operating Losses And Temporary Differences Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToNetOperatingLossesAndTemporaryDifferencesAmount	54937000	usd
CY2024	accd	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Acquisitions Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToAcquisitionsAmount	0	usd
CY2023	accd	Valuation Allowance Deferred Tax Asset Increase Decrease Due To Acquisitions Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseDueToAcquisitionsAmount	-5137000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	178097000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	175610000	usd
CY2024Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	2959000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-99805000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-459650000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-123124000	usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.45
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.45
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.93
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.93
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74906938	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74906938	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71279831	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71279831	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63823270	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63823270	shares
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15802941	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19140581	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17530371	shares
CY2021Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	3700000	usd
CY2024Q1	us-gaap	Purchase Obligation PurchaseObligation	40323000	usd
CY2024Q1	accd	Purchase Obligation Remaining Future Purchase Commitments PurchaseObligationRemainingFuturePurchaseCommitments	22588000	usd
CY2024	us-gaap	Severance Costs1 SeveranceCosts1	864000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	7065000	usd
CY2022Q1	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	7065000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	3069000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	3996000	usd
CY2024	us-gaap	Severance Costs1 SeveranceCosts1	864000	usd
CY2024	us-gaap	Payments For Restructuring PaymentsForRestructuring	4860000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	0	usd

Files In Submission

Name	View Source	Status
0001481646-24-000020-index-headers.html	Edgar Link	pending
0001481646-24-000020-index.html	Edgar Link	pending
0001481646-24-000020.txt	Edgar Link	pending
0001481646-24-000020-xbrl.zip	Edgar Link	pending
accd-20240229.htm	Edgar Link	pending
accd-20240229.xsd	Edgar Link	pending
accd-20240229xex211.htm	Edgar Link	pending
accd-20240229xex231.htm	Edgar Link	pending
accd-20240229xex311.htm	Edgar Link	pending
accd-20240229xex312.htm	Edgar Link	pending
accd-20240229xex321.htm	Edgar Link	pending
accd-20240229_g1.jpg	Edgar Link	pending
clawbackpolicy-ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
accd-20240229_def.xml	Edgar Link	unprocessable
accd-20240229_lab.xml	Edgar Link	unprocessable
accd-20240229_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
accd-20240229_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
accd-20240229_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACCD
Accolade, Inc. Stock $accd

2024 Q2 Form 10-K Financial Statement

#000148164624000020 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACCD Accolade, Inc. Stock $accd

2024 Q2 Form 10-K Financial Statement

#000148164624000020 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACCD
Accolade, Inc. Stock $accd